VanEck Biotech ETF BBH
252.73 USD -1.74 (-0.68%)
Regular-session close
252.81 +0.08 +0.03%
After hours · Nov 13, 4:00 PM ET
251.79 Day range 254.67
179.90 52-week range 261.63
- YTD
- +33.54%
- 1 year
- +34.60%
News
fool.com Simplify Health Care ETF vs. VanEck Biotech ETF: One Critical Difference Could Shape Future Returns Simplify Health Care ETF uses active management to invest across the broader healthcare industry. VanEck Biotech ETF concentrates on 25 biotechnology companies and carries a lower expense ratio.
benzinga.com Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle Natera rises after a Delaware court grants a 30% ongoing royalty in its MRD patent battle with ArcherDx and Invitae.
benzinga.com Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps Vertex's kidney drug delivers a "clear win" in Phase 3. Clinical success and a 6% premarket jump signal a massive milestone for VRTX.
benzinga.com Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval…
benzinga.com Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
benzinga.com New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this…
benzinga.com Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating…
benzinga.com FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits - benzinga.com US Judge Weighs Nationwide Ban On Abortion Pills U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is…
benzinga.com FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' - benzinga.com 5 Top ETFs With Exposure To Biogen For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.
benzinga.com 3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a- benzinga.com Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
- benzinga.com Clinton's Proposal To Combat Drug Price Hikes
- benzinga.com Biotech And Natural Gas ETFs On A Roll
- benzinga.com Biotech Breakout Highlights Flawed ETF Thinking
- benzinga.com ETFs to Watch August 6, 2013 (BSV, KOLD, THD)
- benzinga.com Seasonal Trends: Three ETFs To Own In August
- benzinga.com Don't Forget About This Small-Cap Health Care ETF
- benzinga.com Interesting Similarities Among 2013's Top-Performing ETFs
- benzinga.com Vertex News Lifts Biotech ETFs
- benzinga.com Under The Hood: An Unheralded Biotech ETF
- benzinga.com Biotech Breakout Boosting ETFs
benzinga.com Investors Cheating Themselves by Focusing on Largest ETFs - benzinga.com Argument For Low Volume ETFs Gains Steam
- benzinga.com ETF Winners that Could Keep Their Momentum (EPHE, FBT, XHB)
- benzinga.com Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)
- benzinga.com The Definitive Biotech ETF Guide (IBB, XBI, FBT)
- benzinga.com Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)
benzinga.com Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, IBB, XBI) - benzinga.com Just What The Doctor Ordered: 4 ETFs For Biotech M&A
- benzinga.com Five Biotech ETFs, Which One Is Worth A Look?